PBM rebate schemes to suppress biosimilar Humira cost patients $6B, IQVIA analysis finds https://drugstorenews.com/pbm-rebate-schemes-suppress-biosimilar-humira-cost-patients-6b-iqvia-analysis-finds The Biosimilars Council released a new analysis by IQVIA that reveals a PBM strategy to protect $2 billion in profits by “strangling” the biosimilar market and preventing savings for patients. The Biosimilars Council, a trade association representing manufacturers of biosimilar medicines, […]
Filed under: General Problems | 1 Comment »